Output details
1 - Clinical Medicine
University of Leeds
Article title
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial
Type
D - Journal article
Title of journal
Journal of Clinical Oncology
Article number
-
Volume number
30
Issue number
14
First page of article
1647
ISSN of journal
0732-183X
Year of publication
2012
URL
-
Number of additional authors
24
Additional information
"The author made a substantial contribution to the conception and design of the study"
"The author made a substantial contribution to carrying out the study (including acquisition of study data)"
"The author made a substantial contribution to analysis and interpretation of study data"
"The author helped draft the output"
"The author helped critique the output for important intellectual content"
Interdisciplinary
-
Cross-referral requested
-
Research group
A - Cancer
Citation count
33
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-
